A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Pfizer
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
The New York Proton Center
Nammi Therapeutics Inc
Janssen Research & Development, LLC
University Health Network, Toronto
Bayer
Wake Forest University Health Sciences
Alliance for Clinical Trials in Oncology
Turning Point Therapeutics, Inc.
GlaxoSmithKline
University of Southern California
Revolution Medicines, Inc.
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Avera McKennan Hospital & University Health Center